Mechanism of inhibiting type I interferon induction by hepatitis B virus X protein

Protein and Cell

Volumn 1, Issue 12, 2010, Pages 1106-1117

  Jiang, Junyi ^a,b   Tang, Hong ^a  

^a INSTITUTE OF BIOPHYSICS   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

deubiquitination; HBV X protein (HBx); hepatitis B virus (HBV); type I interferon

Indexed keywords

DEUBIQUITINATING ENZYME; ENZYME; HEPATITIS B VIRUS X PROTEIN; I KAPPA B KINASE EPSILON; I KAPPA B KINASE GAMMA; INTERFERON; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; RETINOIC ACID INDUCIBLE PROTEIN I; TANK BINDING KINASE 1; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN HEK293; CELL STRAIN HEPG2; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INNATE IMMUNITY; INTRACELLULAR SIGNALING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; UBIQUITINATION; VIRUS REPLICATION;

HEPATITIS B VIRUS; SENDAI VIRUS; STEALTH VIRUS;

EID: 79953137779     PISSN: 1674800X     EISSN: 16748018     Source Type: Journal    
DOI: 10.1007/s13238-010-0141-8     Document Type: Article

References (50)

1. Akira, S., Uematsu, S., and Takeuchi, O. (2006). Pathogen recognition and innate immunity. Cell 124, 783-801.
2. Bhoj, V. G., and Chen, Z. J. (2009). Ubiquitylation in innate and adaptive immunity. Nature 458, 430-437.
3. Bouchard, M. J., and Schneider, R. J. (2004). The enigmatic X gene of hepatitis B virus. J Virol 78, 12725-12734.
4. Bowie, A. G., and Unterholzner, L. (2008). Viral evasion and subversion of pattern-recognition receptor signalling. Nat Rev Immunol 8, 911-922.
5. Christen, V., Duong, F., Bernsmeier, C., Sun, D., Nassal, M., and Heim, M. H. (2007). Inhibition of alpha interferon signaling by hepatitis B virus. J Virol 81, 159-165.
6. Dienstag, J. L. (2008). Hepatitis B virus infection. N Engl J Med 359, 1486-1500.
7. Dunn, C., Peppa, D., Khanna, P., Nebbia, G., Jones, M., Brendish, N., Lascar, R. M., Brown, D., Gilson, R. J., Tedder, R. J., et al. (2009). Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 137, 1289-1300.
8. Fernández, M., Quiroga, J. A., and Carreño, V. (2003). Hepatitis B virus downregulates the human interferon-inducible MxA promoter through direct interaction of precore/core proteins. J Gen Virol 84, 2073-2082.
9. Fisicaro, P., Valdatta, C., Boni, C., Massari, M., Mori, C., Zerbini, A., Orlandini, A., Sacchelli, L., Missale, G., and Ferrari, C. (2009). Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut 58, 974-982.
10. Friedman, C. S., O'Donnell, M. A., Legarda-Addison, D., Ng, A., Cárdenas, W. B., Yount, J. S., Moran, T. M., Basler, C. F., Komuro, A., Horvath, C. M., et al. (2008). The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep 9, 930-936.
11. Gack, M. U., Shin, Y. C., Joo, C. H., Urano, T., Liang, C., Sun, L., Takeuchi, O., Akira, S., Chen, Z., Inoue, S., et al. (2007). TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446, 916-920.
12. Gao, D., Yang, Y. K., Wang, R. P., Zhou, X., Diao, F. C., Li, M. D., Zhai, Z. H., Jiang, Z. F., and Chen, D. Y. (2009). REUL is a novel E3 ubiquitin ligase and stimulator of retinoic-acid-inducible gene-I. PLoS One 4, e5760.
13. Guo, B., and Cheng, G. (2007). Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK. J Biol Chem 282, 11817-11826.
14. Guy, C. S., Mulrooney-Cousins, P. M., Churchill, N. D., and Michalak, T. I. (2008). Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus. J Virol 82, 8579-8591.
15. Hochstrasser, M. (2009). Origin and function of ubiquitin-like proteins. Nature 458, 422-429.
16. Honda, K., Takaoka, A., and Taniguchi, T. (2006). Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity 25, 349-360.
17. Kawagoe, T., Takeuchi, O., Takabatake, Y., Kato, H., Isaka, Y., Tsujimura, T., and Akira, S. (2009). TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis. Nat Immunol 10, 965-972.
18. Kawai, T., Sato, S., Ishii, K. J., Coban, C., Hemmi, H., Yamamoto, M., Terai, K., Matsuda, M., Inoue, J., Uematsu, S., et al. (2004). Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 5, 1061-1068.
19. Kayagaki, N., Phung, Q., Chan, S., Chaudhari, R., Quan, C., O'Rourke, K. M., Eby, M., Pietras, E., Cheng, G., Bazan, J. F., et al. (2007). DUBA: a deubiquitinase that regulates type I interferon production. Science 318, 1628-1632.
20. Li, K., Chen, Z., Kato, N., Gale, M. Jr, and Lemon, S. M. (2005). Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes. J Biol Chem 280, 16739-16747.
21. Lok, A. S., and McMahon, B. J. (2007). Chronic hepatitis B. Hepatology 45, 507-539.
22. McCartney, S. A., and Colonna, M. (2009). Viral sensors: diversity in pathogen recognition. Immunol Rev 227, 87-94.
23. Medzhitov, R. (2007). Recognition of microorganisms and activation of the immune response. Nature 449, 819-826.
24. Melegari, M., Scaglioni, P. P., and Wands, J. R. (1998). Cloning and characterization of a novel hepatitis B virus x binding protein that inhibits viral replication. J Virol 72, 1737-1743.
25. O'Neill, L. A. (2009). DNA makes RNA makes innate immunity. Cell 138, 428-430.
26. Oshiumi, H., Matsumoto, M., Hatakeyama, S., and Seya, T. (2009). Riplet/RNF135, a RING finger protein, ubiquitinates RIG-I to promote interferon-beta induction during the early phase of viral infection. J Biol Chem 284, 807-817.
27. Pang, R., Lee, T. K., Poon, R. T., Fan, S. T., Wong, K. B., Kwong, Y. L., and Tse, E. (2007). Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis. Gastroenterology 132, 1088-1103.
28. Randall, R. E., and Goodbourn, S. (2008). Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89, 1-47.
29. Randow, F., and Lehner, P. J. (2009). Viral avoidance and exploitation of the ubiquitin system. Nat Cell Biol 11, 527-534.
30. Reyes-Turcu, F. E., Ventii, K. H., and Wilkinson, K. D. (2009). Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu Rev Biochem 78, 363-397.
31. Sabbah, A., Chang, T. H., Harnack, R., Frohlich, V., Tominaga, K., Dube, P. H., Xiang, Y., and Bose, S. (2009). Activation of innate immune antiviral responses by Nod2. Nat Immunol 10, 1073-1080.
32. Saitoh, T., Tun-Kyi, A., Ryo, A., Yamamoto, M., Finn, G., Fujita, T., Akira, S., Yamamoto, N., Lu, K. P., and Yamaoka, S. (2006). Negative regulation of interferon-regulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nat Immunol 7, 598-605.
33. Schroder, K., Muruve, D. A., and Tschopp, J. (2009). Innate immunity: cytoplasmic DNA sensing by the AIM2 inflammasome. Curr Biol 19, R262-R265.
34. Tang, H., Delgermaa, L., Huang, F., Oishi, N., Liu, L., He, F., Zhao, L., and Murakami, S. (2005). The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication. J Virol 79, 5548-5556.
35. Tenoever, B. R., Ng, S. L., Chua, M. A., McWhirter, S. M., GarcÍa-Sastre, A., and Maniatis, T. (2007). Multiple functions of the IKKrelated kinase IKKepsilon in interferon-mediated antiviral immunity. Science 315, 1274-1278.
36. Wang, C., Chen, T., Zhang, J., Yang, M., Li, N., Xu, X., and Cao, X. (2009). The E3 ubiquitin ligase Nrdp1' preferentially' promotes TLR-mediated production of type I interferon. Nat Immunol 10, 744-752.
37. Wang, H., and Ryu, W. S. (2010). Hepatitis B virus polymerase blocks pattern recognition receptor signaling via interaction with DDX3: implications for immune evasion. PLoS Pathog 6, e1000986.
38. Wang, X., Li, Y., Mao, A., Li, C., Li, Y., and Tien, P. (2010). Hepatitis B virus X protein suppresses virus-triggered IRF3 activation and IFNbeta induction by disrupting the VISA-associated complex. Cell Mol Immunol 7, 341-348.
39. Weber, S., Maass, F., Schuemann, M., Krause, E., Suske, G., and Bauer, U. M. (2009). PRMT1-mediated arginine methylation of PIAS1 regulates STAT1 signaling. Genes Dev 23, 118-132.
40. Webster, G. J., Reignat, S., Maini, M. K., Whalley, S. A., Ogg, G. S., King, A., Brown, D., Amlot, P. L., Williams, R., Vergani, D., et al. (2000). Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 32, 1117-1124.
41. Wei, C., Ni, C., Song, T., Liu, Y., Yang, X., Zheng, Z., Jia, Y., Yuan, Y., Guan, K., Xu, Y., et al. (2010). The hepatitis B virus X protein disrupts innate immunity by downregulating mitochondrial antiviral signaling protein. J Immunol 185, 1158-1168.
42. Whitten, T. M., Quets, A. T., and Schloemer, R. H. (1991). Identification of the hepatitis B virus factor that inhibits expression of the beta interferon gene. J Virol 65, 4699-4704.
43. Wieland, S., Thimme, R., Purcell, R. H., and Chisari, F. V. (2004). Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci U S A 101, 6669-6674.
44. Wieland, S. F., and Chisari, F. V. (2005). Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol 79, 9369-9380.
45. Wu, J., Meng, Z., Jiang, M., Pei, R., Trippler, M., Broering, R., Bucchi, A., Sowa, J. P., Dittmer, U., Yang, D., et al. (2009). Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells. Hepatology 49, 1132-1140.
46. Wu, M., Xu, Y., Lin, S., Zhang, X., Xiang, L., and Yuan, Z. (2007). Hepatitis B virus polymerase inhibits the interferon-inducible MyD88 promoter by blocking nuclear translocation of Stat1. J Gen Virol 88, 3260-3269.
47. Zeng, W., Sun, L., Jiang, X., Chen, X., Hou, F., Adhikari, A., Xu, M., and Chen, Z. J. (2010). Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 141, 315-330.
48. Zeng, W., Xu, M., Liu, S., Sun, L., and Chen, Z. J. (2009). Key role of Ubc5 and lysine-63 polyubiquitination in viral activation of IRF3. Mol Cell 36, 315-325.
49. Zhao, T., Yang, L., Sun, Q., Arguello, M., Ballard, D. W., Hiscott, J., and Lin, R. (2007). The NEMO adaptor bridges the nuclear factorkappaB and interferon regulatory factor signaling pathways. Nat Immunol 8, 592-600.
50. Zheng, D., Chen, G., Guo, B., Cheng, G., and Tang, H. (2008). PLP2, a potent deubiquitinase from murine hepatitis virus, strongly inhibits cellular type I interferon production. Cell Res 18, 1105-1113.